Mary Kay Fenton
Chief Financial Officer · 2 filings · Latest: Feb 20, 2026
Cullinan Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CGEM | Mary Kay Fenton | Chief Financial Officer | Feb 20, 2026 | Sale | $13.62 | 4,398 | $59.9K | 126,380 |